Dr. David M. Spector
Claim this profileGenesis Cancer Care Institute
Studies Cancer
Studies Lung Cancer
20 reported clinical trials
39 drugs studied
About David M. Spector
Education:
- Earned an MD from the University of Iowa Carver College of Medicine in 1987.
Experience:
- Currently a Radiation Oncologist at Genesis Cancer Care Institute.
- Board Certified in Radiation Oncology by the American Board of Radiology.
- Completed both a Fellowship and Residency in Radiation Oncology at the University of California, San Francisco.
- Undertook an Internship in Internal Medicine at the University of Iowa Hospitals and Clinics.
Area of expertise
1Cancer
Stage III
Stage IV
Stage II
2Lung Cancer
Stage III
Stage II
Stage I
Affiliated Hospitals
Clinical Trials David M. Spector is currently running
Genetic Testing
for Early-Stage Lung Cancer
This ALCHEMIST trial studies genetic testing in screening patients with stage IB-IIIA non-small cell lung cancer that has been or will be removed by surgery. Studying the genes in a patient's tumor cells may help doctors select the best treatment for patients that have certain genetic changes.
Recruiting0 awards N/A4 criteria
Crizotinib
for Non-Small Cell Lung Cancer
This randomized phase III trial studies how well crizotinib works in treating patients with stage IB-IIIA non-small cell lung cancer that has been removed by surgery and has a mutation in a protein called anaplastic lymphoma kinase (ALK). Mutations, or changes, in ALK can make it very active and important for tumor cell growth and progression. Crizotinib may stop the growth of tumor cells by blocking the ALK protein from working. Crizotinib may be an effective treatment for patients with non-small cell lung cancer and an ALK fusion mutation.
Recruiting2 awards Phase 328 criteria
More about David M. Spector
Clinical Trial Related4 years of experience running clinical trials · Led 20 trials as a Principal Investigator · 9 Active Clinical TrialsTreatments David M. Spector has experience with
- Paclitaxel
- Pembrolizumab
- Carboplatin
- Gemcitabine Hydrochloride
- Leucovorin Calcium
- Fluorouracil
Breakdown of trials David M. Spector has run
Cancer
Lung Cancer
Non-Small Cell Lung Cancer
Breast Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does David M. Spector specialize in?
David M. Spector focuses on Cancer and Lung Cancer. In particular, much of their work with Cancer has involved Stage III patients, or patients who are Stage IV.
Is David M. Spector currently recruiting for clinical trials?
Yes, David M. Spector is currently recruiting for 8 clinical trials in Davenport Iowa. If you're interested in participating, you should apply.
Are there any treatments that David M. Spector has studied deeply?
Yes, David M. Spector has studied treatments such as Paclitaxel, Pembrolizumab, Carboplatin.
What is the best way to schedule an appointment with David M. Spector?
Apply for one of the trials that David M. Spector is conducting.
What is the office address of David M. Spector?
The office of David M. Spector is located at: Genesis Cancer Care Institute, Davenport, Iowa 52804 United States. This is the address for their practice at the Genesis Cancer Care Institute.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.